These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16780988)

  • 1. Fatigue and neuromuscular diseases.
    Féasson L; Camdessanché JP; El Mandhi L; Calmels P; Millet GY
    Ann Readapt Med Phys; 2006 Jul; 49(6):289-300, 375-84. PubMed ID: 16780988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experienced and physiological fatigue in neuromuscular disorders.
    Schillings ML; Kalkman JS; Janssen HM; van Engelen BG; Bleijenberg G; Zwarts MJ
    Clin Neurophysiol; 2007 Feb; 118(2):292-300. PubMed ID: 17166763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fatigue in neuromuscular disease].
    Van Engelen BG; Kalkman JS; Schillings ML; Van Der Werf SP; Bleijenberg G; Zwarts MJ
    Ned Tijdschr Geneeskd; 2004 Jul; 148(27):1336-41. PubMed ID: 15283024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical neurophysiology of fatigue.
    Zwarts MJ; Bleijenberg G; van Engelen BG
    Clin Neurophysiol; 2008 Jan; 119(1):2-10. PubMed ID: 18039594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of neuromuscular disorders affecting respiratory function.
    Gilchrist JM
    Semin Respir Crit Care Med; 2002 Jun; 23(3):191-200. PubMed ID: 16088611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What we do not know about pregnancy in hereditary neuromuscular disorders.
    Argov Z; de Visser M
    Neuromuscul Disord; 2009 Oct; 19(10):675-9. PubMed ID: 19692244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and management of fatigue in neuromuscular disease.
    Lou JS; Weiss MD; Carter GT
    Am J Hosp Palliat Care; 2010 Mar; 27(2):145-57. PubMed ID: 20190203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of interval-training on fatigue and functional capacities in Charcot-Marie-Tooth disease.
    El Mhandi L; Millet GY; Calmels P; Richard A; Oullion R; Gautheron V; Féasson L
    Muscle Nerve; 2008 May; 37(5):601-10. PubMed ID: 18335470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Techniques in assessing fatigue in neuromuscular diseases.
    Lou JS
    Phys Med Rehabil Clin N Am; 2012 Feb; 23(1):11-22, ix. PubMed ID: 22239870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The repetitive stimulation test in the diagnosis of neuromuscular fatigue syndromes. Critical review of the results in 62 cases].
    Negrin P; Fardin P
    Riv Neurol; 1979; 49(4):297-309. PubMed ID: 550291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain in hereditary neuromuscular disorders and myasthenia gravis: a national survey of frequency, characteristics, and impact.
    Guy-Coichard C; Nguyen DT; Delorme T; Boureau F
    J Pain Symptom Manage; 2008 Jan; 35(1):40-50. PubMed ID: 17981001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.
    Carter GT; Han JJ; Mayadev A; Weiss MD
    Am J Hosp Palliat Care; 2006; 23(5):412-6. PubMed ID: 17060310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    Eur Neurol; 2006; 56(1):24-30. PubMed ID: 16914927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical approach to the weak patient in the intensive care unit.
    Dhand UK
    Respir Care; 2006 Sep; 51(9):1024-40; discussion 1040-1. PubMed ID: 16934166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire.
    Vandervelde L; Van den Bergh PY; Goemans N; Thonnard JL
    Neuromuscul Disord; 2009 Feb; 19(2):99-103. PubMed ID: 19167889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating contraction level using root mean square amplitude in control subjects and patients with neuromuscular disorders.
    Boe SG; Rice CL; Doherty TJ
    Arch Phys Med Rehabil; 2008 Apr; 89(4):711-8. PubMed ID: 18374002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content].
    Konagaya M; Konagaya Y; Horikawa H; Iida M
    Rinsho Shinkeigaku; 1990 Oct; 30(10):1078-83. PubMed ID: 1703936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employment status of patients with neuromuscular diseases in relation to personal factors, fatigue and health status: a secondary analysis.
    Minis MA; Kalkman JS; Akkermans RP; Engels JA; Huijbregts PA; Bleijenberg G; Oostendorp RA; van Engelen BG
    J Rehabil Med; 2010 Jan; 42(1):60-5. PubMed ID: 20111846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.